Blood Group--kell System; Kel

Description

The Kell blood group system is formed by 2 disulfide-linked proteins, Kell and XK. The Kell protein is a type II membrane glycoprotein sharing sequence homology with members of the M13 family of zinc-dependent metalloproteases and possessing enzymatic activity characteristic of that group (summary by Claperon et al., 2007).The Kell blood group system is highly polymorphic, expressing over 25 antigens that have been classified in to 5 antithetical sets of high and low prevalence antigens with the others being independently expressed or having unknown antithetical partners. The different phenotypes are due to single-nucleotide mutations that result in an amino acid substitution (summary by Sha et al., 2006). See, for example, Kell (designated K or K1)/Cellano (k, K2) (T193M; {613883.0001}).Yu et al. (2001) noted that the Kell antigens are the most potent immunogens aside from the A and B antigens of the ABO system (OMIM ) and the D antigen (OMIM ) of the Rh system (see {111700}).

Clinical Features

Phenotypes and symptoms related to Blood Group--kell System; Kel

  • Anemia
  • Abnormality of the nervous system
  • Hemolytic anemia
  • Acanthocytosis

Incidence and onset information

— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)
No data available about the known clinical features onset.

Alternative names

Blood Group--kell System; Kel Is also known as blood group--kell-cellano system.

Researches and researchers

Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.

Blood Group--kell System; Kel Recommended genes panels

Panel Name, Specifity and genes Tested/covered
Kell K/k Antigen (KEL) Genotyping.

By ARUP Laboratories, Molecular Genetics and Genomics (United States).

KEL
Specificity
100 %
Genes
100 %
Hemolytic anemia, Kell-system related.

By Centogene AG - the Rare Disease Company (Germany).

KEL
Specificity
100 %
Genes
100 %
Kell (K1/K2).

By BloodCenter of Wisconsin Diagnostic Laboratories BloodCenter of Wisconsin, part of Versiti (United States).

KEL
Specificity
100 %
Genes
100 %
Kell (K6/K7) (Jsa/Jsb).

By BloodCenter of Wisconsin Diagnostic Laboratories BloodCenter of Wisconsin, part of Versiti (United States).

KEL
Specificity
100 %
Genes
100 %
Red Cell Genotyping Panel.

By BloodCenter of Wisconsin Diagnostic Laboratories BloodCenter of Wisconsin, part of Versiti (United States).

RHCE, RHD, SLC14A1, ACKR1, GYPA, GYPB, KEL, BCAM, ART4
Specificity
12 %
Genes
100 %
KEL.

By Fulgent Genetics Fulgent Genetics (United States).

KEL
Specificity
100 %
Genes
100 %
NeoTYPE® Discovery Profile for Solid Tumors.

By NeoGenomics Laboratories NeoGenomics Laboratories, Inc. (United States).

BCL6, ROS1, RUNX1, BLM, SDHA, SDHB, SDHC, SDHD, SF3B1, FOXL2, BRAF, BRCA1, BRCA2, SLIT2, SMARCA4, SMARCB1, ARID1A, KDM5C, SMO, SNCAIP , (...)

View the complete list with 288 more genes
Specificity
1 %
Genes
100 %
Tempus xT assay.

By Tempus Labs, Inc. (United States).

BCL6, RIT1, BCL7A, BCR, ROS1, RPL5, RPS15, RPS6KB1, RUNX1, RXRA, BLM, SDHA, SDHB, SDHC, SDHD, SEC23B, SEMA3C, BMPR1A, SF3B1, SRSF2 , (...)

View the complete list with 555 more genes
Specificity
1 %
Genes
100 %

You can get up to 1 more panels with our dedicated tool

Learn more

Sources and references

You can check the following sources for additional information.

OMIM Rare Disease Search Engine

If you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY; SRTD6 SPASTIC PARAPLEGIA 17, AUTOSOMAL DOMINANT; SPG17 POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL MAZABRAUD SYNDROME ASTHMA, SUSCEPTIBILITY TO ALVEOLAR CAPILLARY DYSPLASIA WITH MISALIGNMENT OF PULMONARY VEINS; ACDMPV MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34